Genesis Healthcare (NYSE:GEN) Trading 5.3% Higher

Genesis Healthcare Inc (NYSE:GEN) traded up 5.3% during mid-day trading on Monday . The company traded as high as $1.62 and last traded at $1.60, 282,183 shares traded hands during trading. An increase of 30% from the average session volume of 217,834 shares. The stock had previously closed at $1.52.

The business’s 50 day moving average price is $1.25 and its 200-day moving average price is $1.22. The company has a market cap of $250.46 million, a price-to-earnings ratio of -1.03 and a beta of 0.92.

Genesis Healthcare (NYSE:GEN) last posted its earnings results on Thursday, August 8th. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.13) by $0.08. The company had revenue of $1.15 billion for the quarter, compared to analyst estimates of $1.15 billion. During the same quarter in the prior year, the business posted ($0.39) EPS. On average, research analysts forecast that Genesis Healthcare Inc will post -0.46 earnings per share for the current fiscal year.

Several hedge funds and other institutional investors have recently bought and sold shares of the company. SG Americas Securities LLC lifted its stake in shares of Genesis Healthcare by 64.0% during the 2nd quarter. SG Americas Securities LLC now owns 50,954 shares of the company’s stock worth $63,000 after buying an additional 19,889 shares during the last quarter. Northern Trust Corp increased its position in Genesis Healthcare by 5.8% during the second quarter. Northern Trust Corp now owns 693,681 shares of the company’s stock worth $861,000 after acquiring an additional 38,188 shares during the period. Bank of New York Mellon Corp increased its position in Genesis Healthcare by 28.6% during the second quarter. Bank of New York Mellon Corp now owns 215,533 shares of the company’s stock worth $268,000 after acquiring an additional 47,981 shares during the period. Claraphi Advisory Network LLC bought a new position in Genesis Healthcare during the second quarter worth about $75,000. Finally, Jane Street Group LLC bought a new position in Genesis Healthcare during the second quarter worth about $83,000. Institutional investors own 20.78% of the company’s stock.

About Genesis Healthcare (NYSE:GEN)

Genesis Healthcare, Inc, together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy.

See Also: Beige Book

Receive News & Ratings for Genesis Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.